Technical Analysis for OVID - Ovid Therapeutics Inc.

Grade Last Price % Change Price Change
grade D 5.81 -3.33% -0.20
OVID closed down 3.33 percent on Monday, October 15, 2018, on 1.54 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Flat
See historical OVID trend table...

Date Alert Name Type % Chg
Oct 15 Fell Below 20 DMA Bearish 0.00%
Oct 15 Bollinger Band Squeeze Range Contraction 0.00%
Oct 15 Gapped Down Weakness 0.00%
Oct 12 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -3.33%
Oct 12 Bollinger Band Squeeze Range Contraction -3.33%
Oct 12 Narrow Range Bar Range Contraction -3.33%
Oct 12 NR7 Range Contraction -3.33%
Oct 12 NR7-2 Range Contraction -3.33%
Oct 12 Up 3 Days in a Row Strength -3.33%
Oct 11 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.84%

Older signals for OVID ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Ovid Therapeutics Inc. (Ovid) is a biopharmaceutical company. The Company is engaged in developing medicines for patients and families living with rare neurological disorders. Its lead drug candidate is OV101. The Company’s second lead drug candidate is OV935. OV101 (gaboxadol) is a delta-selective GABAA receptor agonist. Ovid is developing OV101 for use in both Angelman syndrome and Fragile X syndrome to potentially restore tonic inhibition and relieve several of the symptoms of these disorders. Ovid has initiated the Phase II STARS trial of OV101 in adults with Angelman syndrome and a Phase I trial in adolescents with Angelman syndrome or Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies.
Is OVID a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 12.44
52 Week Low 5.2
Average Volume 91,924
200-Day Moving Average 7.9719
50-Day Moving Average 6.1139
20-Day Moving Average 5.8185
10-Day Moving Average 5.83
Average True Range 0.4302
ADX 19.58
+DI 16.8493
-DI 20.8329
Chandelier Exit (Long, 3 ATRs ) 5.0394
Chandelier Exit (Short, 3 ATRs ) 6.4906
Upper Bollinger Band 6.1208
Lower Bollinger Band 5.5162
Percent B (%b) 0.49
BandWidth 10.390994
MACD Line -0.1244
MACD Signal Line -0.1962
MACD Histogram 0.0717
Fundamentals Value
Market Cap 142.93 Million
Num Shares 24.6 Million
EPS -4.85
Price-to-Earnings (P/E) Ratio -1.20
Price-to-Sales 0.00
Price-to-Book 1.52
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.40
Resistance 3 (R3) 6.39 6.19 6.30
Resistance 2 (R2) 6.19 6.04 6.19 6.26
Resistance 1 (R1) 6.00 5.95 5.90 6.01 6.23
Pivot Point 5.80 5.80 5.75 5.80 5.80
Support 1 (S1) 5.61 5.65 5.51 5.62 5.39
Support 2 (S2) 5.41 5.56 5.41 5.36
Support 3 (S3) 5.22 5.41 5.32
Support 4 (S4) 5.23